- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
8 result(s) found for: Anaerobic bacteria.
Displaying page 1 of 1.
| EudraCT Number: 2006-004811-22 | Sponsor Protocol Number: ABR 14357 | Start Date*: 2008-04-01 | |||||||||||
| Sponsor Name:Erasmus Medical Center Rotterdam | |||||||||||||
| Full Title: A prospective, randomized, double-blind comparison of 5 % against 1 % povidone-iodine solution in preoperative antisepsis for strabismus surgery in young children. | |||||||||||||
| Medical condition: Endophthalmitis (E) after strabismus surgery (S) leading to blindness is caused by eyelid and conjunctival bacteria. Povidone-iodine(PI) solutions between 1% and 5% reduce the number of bacteria on... | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-002239-29 | Sponsor Protocol Number: WI18274 | Start Date*: 2006-03-06 |
| Sponsor Name:F. Hoffmann - La Roche AG | ||
| Full Title: A phase II prospective, open label, randomized, active-controlled, parallel group, multi-center ‘proof of concept’ trial in adult patients with complicated skin and skin structure infections requir... | ||
| Medical condition: Treatment of adult patients with complicated skin and skin structure infections requiring hospitalization. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: LT (Completed) EE (Completed) DE (Completed) LV (Completed) HU (Completed) GR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-004505-14 | Sponsor Protocol Number: Modic02 | Start Date*: 2015-03-04 |
| Sponsor Name:Oslo University Hospital HF, Ullevål Hospital, FORMI-Formidlingsenheten for muskel- og skjelettlidelser | ||
| Full Title: Antibiotic treatment in patients with chronic low back pain and Modic Changes: a double-blind randomized placebo-controlled trial | ||
| Medical condition: A recent Danish study published during spring 2013 advances a remarkable cause and treatment with Amoxicillin for a selected sub-group of low back pain patients.The study was based upon a hypothesi... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NO (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-000694-24 | Sponsor Protocol Number: X-00069-3322 | Start Date*: 2020-02-03 |
| Sponsor Name:Meda Pharma GmbH & Co. KG (A Mylan company) | ||
| Full Title: Evaluation of the antiseptic activity of 4 different modes of application of a 5% alcoholic povidone-iodine product (Bétadine® Alcoolique 5%) | ||
| Medical condition: Healthy volunteers | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-000492-32 | Sponsor Protocol Number: AMIII | Start Date*: 2019-01-14 |
| Sponsor Name:Charité-Universitätsmedizin Berlin | ||
| Full Title: Effects of antibiotics on micobiota, pulmonary immune response and incidence of ventilator-associated infections | ||
| Medical condition: mechanically ventilated patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-002726-39 | Sponsor Protocol Number: D4910C00009/C3601001 | Start Date*: 2016-02-25 |
| Sponsor Name:Pfizer Inc. | ||
| Full Title: A Phase IIa prospective, open-label, multicenter study to determine the pharmacokinetics (PK) and safety and tolerability of aztreonam-avibactam (ATM-AVI) for the treatment of complicated Intra-Abd... | ||
| Medical condition: Complicated Intra-Abdominal Infections (cIAIs) in hospitalized adults | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-004579-16 | Sponsor Protocol Number: FU-04-21 | Start Date*: 2022-01-18 | |||||||||||
| Sponsor Name:Adamed Pharma S.A. | |||||||||||||
| Full Title: A Phase II, Randomized, Parallel design, Open label, Dose ranging Study to evaluate the efficacy and safety of Furazidin vaginal tablets in women with bacterial vaginosis | |||||||||||||
| Medical condition: Bacterial Vaginosis (BV) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: PL (Completed) HU (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-007659-15 | Sponsor Protocol Number: NC-07-03 | Start Date*: 2008-04-22 | ||||||||||||||||||||||||||
| Sponsor Name:Lumavita AG | ||||||||||||||||||||||||||||
| Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Investigate the Efficacy, Safety, and Tolerability of 3 doses of SPK 0602 (pentamycin) Vaginal Tablets vs Placebo (veh... | ||||||||||||||||||||||||||||
| Medical condition: Symptomatic Vaginitis due to Bacterial Vaginosis, Candidiasis or Trichomoniasis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
| Trial protocol: EE (Completed) DE (Completed) HU (Completed) | ||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.